Mebendazole/Levamisole Hydrochloride

甲苯咪唑/盐酸左旋咪唑

Report date: 2024/04/09 16:23:14
NME

Base Information

Drug NameMebendazole/Levamisole Hydrochloride
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionImmunomodulatorsMicrotubule-associated proteins inhibitors
TargetsMicrotubule-associated proteins
Therapy Area/IndicationsAncylostomiasisStrongyloidiasisEnterobiasis +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes MebendazoleLevamisole Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsAncylostomiasisStrongyloidiasisEnterobiasis +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeP
Related LinksN/A